SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-209866
Filing Date
2021-07-07
Accepted
2021-07-07 16:02:02
Documents
16
Period of Report
2021-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d329652d8k.htm   iXBRL 8-K 30301
2 EX-99.1 d329652dex991.htm EX-99.1 36361
6 GRAPHIC g329652g0707022306618.jpg GRAPHIC 2501
7 GRAPHIC g329652img001a.jpg GRAPHIC 17616
8 GRAPHIC g329652img002b.jpg GRAPHIC 9682
  Complete submission text file 0001193125-21-209866.txt   243715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alec-20210701.xsd EX-101.SCH 2876
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20210701_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20210701_pre.xml EX-101.PRE 11852
9 EXTRACTED XBRL INSTANCE DOCUMENT d329652d8k_htm.xml XML 3448
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 211077444
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences